JBC GenomeOne product landing page

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M205985200 on July 30, 2002

J. Biol. Chem., Vol. 277, Issue 40, 37191-37200, October 4, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/40/37191    most recent
M205985200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, Q.
Right arrow Articles by Maity, S. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, Q.
Right arrow Articles by Maity, S. N.

CCAAT Binding Factor (CBF) Binding Mediates Cell Cycle Activation of Topoisomerase IIalpha
CONVENTIONAL CBF ACTIVATION DOMAINS ARE NOT REQUIRED*

Qianghua HuDagger , Chitralekha BhattacharyaDagger , and Sankar N. Maity§

From the Department of Molecular Genetics, The University of Texas, M. D. Anderson Cancer Center, Houston, Texas 77030

To understand the role of the CCAAT binding factor (CBF) in transcription during the cell cycle, we studied the mouse topoisomerase IIalpha (topo IIalpha ) promoter, which is activated during the late S and G2/M phases of the cell cycle and contains multiple CBF binding sites. Mutational analysis of the promoter shows that CBF binding to an inverted orientation of the CCAAT motif in the topo IIalpha promoter, but not to a direct orientation, is required for transcription activation during the cell cycle. In contrast, analysis of the promoter in an in vitro reconstituted transcription system shows that CBF activates transcription of the topo IIalpha promoter irrespective of the orientation of the CBF binding sites. This analysis demonstrates that only one of the three transcription start sites of the topo IIalpha promoter is stimulated by CBF, indicating that transcription activation by CBF is dependent on basal promoter structure. Interestingly, mutations of the start site that abolish CBF-dependent transcription activation in vitro do not inhibit activation of the promoter during the cell cycle. Consistent with this observation, expression of a truncated CBF-B subunit lacking a transcription activation domain, which inhibits activity of a collagen promoter, does not affect activity of the topo IIalpha promoter in fibroblast cells. In contrast, expression of an allele-specific CBF-B mutant that binds high affinity to a mutant CBF binding site containing a CCAAC motif revives transcription activation of an inactive mutant topo IIalpha promoter containing CCAAC during the cell cycle. Altogether, this study indicates that CBF binding, but not conventional CBF activation domains, are required for activation of the topo IIalpha promoter during the cell cycle. Considering these results together with results of another recent study, we hypothesize that binding of CBF that disrupts the nucleosomal structure in the topo IIalpha promoter is a major function of CBF by which it regulates the cell cycle-dependent transcription of the topo IIalpha promoter and possibly many other cell cycle-regulated promoters containing CBF binding sites.


* This work was supported by National Institutes of Health Grant R01 AR46264 (to S. N. M.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger These authors contributed equally to this study.

§ To whom correspondence should be addressed: Dept. of Molecular Genetics, Box 11, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030. Tel.: 713-792-8943; Fax: 713-794-4295; E-mail: smaity@mdanderson.org.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.


This article has been cited by other articles:


Home page
GENES CELLSHome page
Y. Yoshioka, O. Suyari, and M. Yamaguchi
Transcription factor NF-Y is involved in regulation of the JNK pathway during Drosophila thorax development.
Genes Cells, February 1, 2008; 13(2): 117 - 130.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. Tokusumi, Y. Ma, X. Song, R. H. Jacobson, and S. Takada
The New Core Promoter Element XCPE1 (X Core Promoter Element 1) Directs Activator-, Mediator-, and TATA-Binding Protein-Dependent but TFIID-Independent RNA Polymerase II Transcription from TATA-Less Promoters
Mol. Cell. Biol., March 1, 2007; 27(5): 1844 - 1858.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S.-H. Park, G.-R. Yu, W.-H. Kim, W.-S. Moon, J.-H. Kim, and D.-G. Kim
NF-Y-Dependent Cyclin B2 Expression in Colorectal Adenocarcinoma
Clin. Cancer Res., February 1, 2007; 13(3): 858 - 867.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
Q. Hu, J.-F. Lu, R. Luo, S. Sen, and S. N. Maity
Inhibition of CBF/NF-Y mediated transcription activation arrests cells at G2/M phase and suppresses expression of genes activated at G2/M phase of the cell cycle
Nucleic Acids Res., December 4, 2006; 34(21): 6272 - 6285.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Chen, A. Unterbrink, S. Kadapakkam, J. Dong, T. T. Gu, J. Dickson, H.-H. Chuang, and M. MacDougall
Regulation of the Cell Type-specific Dentin Sialophosphoprotein Gene Expression in Mouse Odontoblasts by a Novel Transcription Repressor and an Activator CCAAT-binding Factor
J. Biol. Chem., October 1, 2004; 279(40): 42182 - 42191.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
C. Chattopadhyay, D. Hawke, R. Kobayashi, and S. N. Maity
Human p32, interacts with B subunit of the CCAAT-binding factor, CBF/NF-Y, and inhibits CBF-mediated transcription activation in vitro
Nucleic Acids Res., July 8, 2004; 32(12): 3632 - 3641.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Bhattacharya, J. M. Deng, Z. Zhang, R. Behringer, B. de Crombrugghe, and S. N. Maity
The B Subunit of the CCAAT Box Binding Transcription Factor Complex (CBF/NF-Y) Is Essential for Early Mouse Development and Cell Proliferation
Cancer Res., December 1, 2003; 63(23): 8167 - 8172.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
I. G. Sharina, E. Martin, A. Thomas, K. L. Uray, and F. Murad
CCAAT-binding factor regulates expression of the {beta}1 subunit of soluble guanylyl cyclase gene in the BE2 human neuroblastoma cell line
PNAS, September 30, 2003; 100(20): 11523 - 11528.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Caretti, V. Salsi, C. Vecchi, C. Imbriano, and R. Mantovani
Dynamic Recruitment of NF-Y and Histone Acetyltransferases on Cell-cycle Promoters
J. Biol. Chem., August 15, 2003; 278(33): 30435 - 30440.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.